Skip to main content

Cencora, Inc. statistics

  • COR · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$359.03+2.76%Close 13 Nov 2026 · Market value $68.14B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Cencora, Inc. is valued at $68.14B on its latest close. Its price is 26.0 times its earnings.

Market value$68.14B
Enterprise value$77.61B
Price / earnings25.96
Price / sales0.20
Price / book22.34
EV / EBITDA19.02
EV / sales0.23
Price / free cash flow16.78
Price / free cash flow, own 5-year average18.02
EV / EBIT25.33
EV / free cash flow18.98
Free cash flow yield6.0%
Dividend yield0.7%

Share price

Latest close$359.03
Day's change+2.8%
52-week high$377.54
52-week low$244.82
From 52-week high−4.9%
Return · 1 month+5.3%
Return · 3 months+14.1%
Return · year to date+6.3%
Return · 1 year−1.2%
Beta · 1 year against the S&P 5000.05
50-day average$327.16
200-day average$316.71
RSI 1466.3
Average volume · 20 sessions1.4M

Margins and returns

For fiscal 2025, as filed.

Gross margin3.6%
Operating margin0.8%
Net margin0.5%
Free cash flow margin1.0%
Return on assets2.5%
Return on invested capital11.1%
Return on invested capital, 5-year average12.0%
Return on capital employed16.6%
Stock-based compensation / revenue0.0%

Financial position

At the end of fiscal 2025.

Cash and equivalents$4.36B
Total debt$9.33B
Net debt$4.98B
Current ratio0.90
Quick ratio0.48
Debt / equity6.19
Net debt / EBITDA1.35

Growth

Revenue, latest quarter on a year+5.1%
Revenue, twelve months on a year+5.1%
EPS, latest quarter on a year+11.9%
EPS, twelve months on a year+39.0%
Revenue, 5-year compound+11.1%
Revenue, 10-year compound+9.0%
Free cash flow, 5-year compound+11.8%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares195M
Shares outstanding, 5-year compound−1.0%
Net share repurchases$406.3M
Dividends per share$2.20
Dividend payout28.1%

Taxes

For fiscal 2025, as filed.

Income tax expense$690.5M
Effective tax rate30.6%

COR in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.